アルツハイマー病の遺伝的リスク
Yining Pan1, Hwayoung Cho2, Qian Lou3
1Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL, USA.
NPJ systems biology and applications
|February 14, 2026
まとめ
アルツハイマー病 (AD) の遺伝子は複雑です. 機械学習ポリジェニックリスクスコア (PRS) は,遺伝子相互作用と性差を考慮して予測を改善し,パーソナライズされたアルツハイマー病リスク評価を進める.
科学分野:
- 遺伝学 遺伝学とは
- 神経科学は神経科学である.
- コンピュータ生物学 コンピュータ生物学
背景:
- アルツハイマー病 (AD) は,有意な遺伝的影響を示しています.
- 全ゲノム関連研究 (GWAS) では,多数のADリスクロシオが特定されています.
- ADリスクに関連する多くの非コーディング遺伝子変異は,未だに十分に理解されていない.
研究 の 目的:
- アルツハイマー病の遺伝的危険因子に関する現在の理解をレビューする.
- 多遺伝子リスクスコア (PRS) の開発方法論を要約する.
- ADリスクの予測における機械学習 (ML) の応用を探求する.
主な方法:
- アルツハイマー病の遺伝学に関する既存の文献のレビュー.
- 多遺伝子リスクスコア (PRS) の構築と検証技術の分析.
- ADの遺伝子データに適用された機械学習 (ML) アルゴリズムの検討.
主要な成果:
- コード化されていない変異を含む遺伝的要因は,ADの傾向に大きく貢献します.
- 多遺伝的リスクスコア (PRS) は,複雑な遺伝的相互作用と性特異的な効果をモデル化することによって,予測力を高めます.
- 機械学習のアプローチは,ADリスク予測の精度を向上させることを約束しています.
結論:
- 多様な遺伝子データと高度な計算方法の統合は,ADの理解に不可欠です.
- 集団バイアスや機能的検証などの課題に取り組むことは,臨床的有用性にとって不可欠です.
- マルチオミックスのデータ統合は,アルツハイマー病の管理における精密医療の可能性を秘めています.
関連する概念動画
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...